In the MC38-Ova tumor model, NP-APC11, but not NP-APC11M, markedly increased the number of H-2Kb-OVA257-264 tetramer+ CD8+ tumor-infiltrating lymphocytes, indicating enhanced antigen-specific T cell infiltration (Fig. 7h). This evidence concerns the gene CD8A and neoplasm.